High Intensity Focused Ultrasound Treatment-Induced Tumor Lysis Syndrome in Uterine Myoma Patient

Tumor lysis syndrome is one of the major oncological emergency. It causes complications such as acute kidney injury, cardiac arrhythmia, and death. However, it is rare in solid tumors. We report on a case of a patient with myoma of uterus who developed tumor lysis syndrome and acute kidney injury after high intensity focused ultrasound (HIFU) treatment. The potential complications of tumor lysis syndrome should be considered in HIFU treatment.

The investigation of macrophage infiltration in the early phase of ischemic acute renal failure in mice

BACKGROUND/AIMS: Inflammation plays a key role in ischemic acute renal failure (ARF). The present study investigated the infiltration of macrophages in the early phase of ischemic ARF in mice. METHODS: Ischemic ARF was induced by renal clamping for 22 min, while the control mice underwent sham surgery (no clamping). The serum creatinine and blood urea nitrogen (BUN) levels were measured in the control and post-ischemia mice. Immunofluorescence staining was used to measure the number of CD 11b-positive cells in the kidney tissue sections to determine the amount of post-ischemic macrophage infiltration. Lipo-Cl2MBP (clodronate) for macrophages depletion was injected via a tail vein 5 d before ischemia induction and again 2 d before ischemia induction. RESULTS: The study found that the post-ischemia mice had higher levels of serum creatinine and BUN at 16 and 24 h compared to the controls. Immunofluorescence staining showed there were more macrophages in the post-ischemic tissue at 2, 8, 16 and 24 h compared to the control tissue, and that most of these macrophages were located in the outer medulla. The mice treated with clodronate prior to ischemia induction were found to have lower levels of serum creatinine compared to those mice that weren't treated with clodronate. CONCLUSIONS: There was significant infiltration of macrophages from the early phase of ischemic ARF, and this peaked at 16-24 h. Macrophage depletion using clodronate was protective against ischemic ARF.

Changes of the Cerebral Metabolite Patterns in Patients Undergoing Hemodialysis due to Chronic Renal Failure: Evaluation with Proton Magnetic Resonance Spectroscopy

PURPOSE: We wanted to evaluate the cerebral metabolites in patients with chronic renal failure (CRF) and who were undergoing hemodialysis by performing proton MR spectroscopy and we wanted to evaluate the correlation between the changes in the cerebral metabolite ratios and the duration after starting the initial hemodialysis. MATERIALS AND METHODS: Proton MR spectroscopy was performed in 15 patients with CRF and who were undergoing hemodialysis and in ten healthy volunteers. The changes in N-acetylaspartate (NAA), choline-containing compounds (Cho), myo-inositol (Myo), glutamine/glutamate complex (Glx), and creatine (Cr) were analyzed. MR spectroscopy was performed before and after hemodialysis. RESULTS: For the patients with CRF before hemodialysis, the Cho/Cr ratio in the gray matter (p<0.001) and the Myo/Cr ratio in both the gray and white matter (p<0.01) were significantly elevated compared with those in the control subjects. For the patients with CRF after hemodialysis, their Cho/Cr ratios were significantly reduced in both the gray and white matter compared with that before hemodialysis (p<0.05). There was a significant positive correlation between the Cho/Cr ratio and serum Cr in the gray matter of CRF patients after hemodialysis (r=0.54, p<0.05). The cerebral metabolite ratios were not significantly correlated with the duration after starting the initial hemodialysis. CONCLUSION: The cerebral metabolite patterns are significantly different between the patients with CRF and who are undergoing hemodialysis and the normal controls. The cerebral metabolite ratios are not significantly correlated with the duration after starting the initial hemodialysis.

Assessment of Fluid Shifts of Body Compartments using Both Bioimpedance Analysis and Blood Volume Monitoring

Fluid shifts are commonplace in chronic hemodialysis patients during the intra- and interdialytic periods. In this study, we evaluated fluid shifts of body compartments using both bioimpedance spectroscopy and blood volume monitoring from the start to the end of hemodialysis. 24 stable hemodialysis patients were included on the study. Relative change of blood volume was progressively reduced from the start to the end of hemodialysis (1 hr, -7.22+/-3.23%; 2 hr, -9.78+/-4.69%; 3 hr, -12.88+/-5.65%; 4 hr, -15.41+/-6.54%, respectively). Mean % reduction of intracellular fluid was not significantly different to that of extracellular fluid at the end of hemodialysis (delta ICF, -6.58+/-5.34% vs. delta ECF, -7.07+/-5.12%). Mean % fluid reduction of arms, legs and trunk was -11.98+/-6.76%, -6.43+/-4.37% and -7.47+/-4.56%, respectively at the end of hemodialysis. There were 3 characteristic patterns in blood-volume change. Similar amounts of fluid were removed from the extracellular and intracellular compartments during hemodialysis, with the arms showing the greatest loss in terms of body segments. The pattern of blood volume change measured by blood volume monitoring may be useful for more accurate determination of dry-weight and for correcting volume status in hemodialysis patients.

Association of serum albumin and homocysteine levels and cardio-ankle vascular index in patients with continuous ambulatory peritoneal dialysis

BACKGROUND: The cardio-ankle vascular index (CAVI) is a newly developed arteriosclerotic measurement that has been proposed as an alternative to aortic pulse-wave velocity (PWV). The present study used the CAVI to identify the main factors associated with arteriosclerosis in continuous ambulatory peritoneal dialysis (CAPD) patients. METHODS: Fifteen CAPD patients were enrolled in the study. The CAVI is independent of the pressure and vascular reflection between the heart valve and the ankle. Serum albumin, uric acid, total calcium, phosphorus, lipid levels, high-sensitivity C-reactive protein and homocysteine concentrations in CAPD patients were measured using standard methods. Total body fat mass, truncal and non-truncal fat mass and lean body mass were measured using dual energy X-ray absorptiometry with a Lunar DPX-L scanner. RESULTS: CAPD patients had a mean CAVI of 9.37+/-3.16 m/sec, which was higher than the general population. The CAVI was negatively correlated with the serum albumin concentration (r=-0.548; p=0.034). Stepwise regression analysis showed that both the serum albumin concentration (beta=-0.643, p=0.013) and the serum homocysteine level (beta=0.486, p=0.004) were independently associated with the CAVI. CONCLUSIONS: An increase in CAVI was independently associated with both serum albumin and homocysteine level.

2 Cases of Gastrointestinal Amyloidosis Presenting Massive Gastrointestinal Bleeding in Predialytic Chronic Renal Failure Patients / 대한신장학회잡지

A case of a 42-year-old man who had massive and refractoty bleeding from multiple gastric ulcers complicating gastric amyloidosis and a case of a 62- year-old woman who had massive hematochezia from rectal amyloidosis in predialytic chronic renal failure patients are reported. Emergency total gastrectomy and simple ligation were performed in two patients. Two patients were confirmed by showing apple green birefringence under the polarized microscope with Congo-red stain through stomach and rectal specimen. Immunoelectrophoresis and protein electrophoresis of serum and urine showed no significant findings. 2 cases of gastrointestinal amyloidosis presenting massive bleeding in predialytic chronic renal failure patients were discussed with brief literature.

A study on changes of serum leptin and its expression in CAPD animal model / 대한내과학회지

BACKGROUND: The ob gene product leptin is thought to be an adipostatic hormone through the regulation of food intake and energy expenditure. There are many reports that serum leptin concentration was increased in CRF patients, especially CAPD patients. Increased body fat mass, decreased residual renal function, active inflammation, hyperinsulinemia and intraperitoneal hyperglycemia all are suggested to influence serum leptin concentration in CAPD patients. In order to investigate the pathogenic mechanism of increased serum leptin concentration in CAPD patients, we observed the changes of serum leptin concentration, leptin expression in the mesenteric and epididymal fat tissue in CAPD animal model. METHOD: 10 CAPD animal models (Sprague-Dawley rat, male) were enrolled in this study. Serum leptin concentration was measured by RIA before start of CAPD (baseline data), 7 days after start of CAPD. Simultaneously, mesenteric and epididymal fat tissues were extracted for analysis of ob gene expression. Ob mRNA expression was measured by northern blot assay. The changes of serum insulin concentration, serum lactate concentration, fasting blood sugar and urine volume were measured. RESULTS: Leptin expression in the mesenteric fat tissue was significantly increased 7 days after start of CAPD (0.19+/-0.03, 0.46+/-0.22, p<0.05). On the contrary, serum leptin concentration and leptin expression in the epididymal fat tissue were decreased 7 days after start of CAPD. Significant increase of serum insulin concentration and urine volume were observed during the study period. CONCLUSION: In these results, hyperleptinemia in CAPD patients may be associated with glucose uptake into the mesenteric fat tissue and decreased residual renal function. Therefore, a study of the changes of serum leptin concentration and leptin expression in fat tissue will be needed in nephrecomized CAPD animal model.